TCL Archive Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested February 11, 1977
TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm January 23, 1998
